Taysha Gene Therapies Inc (TSHA)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||
| Total Revenue | 0 | 0 | 2.5M | 4.71M | 2.4M | 4.75M | 3.6M | 3.41M |
| Operating Income | -32.99M | -25.07M | -18.7M | -16.56M | -23.38M | -15.63M | -15.8M | -24.33M |
| Pre Tax Income | -33.87M | -26.31M | -55.72M | -17.62M | -24.6M | -117.09M | 47.74M | -24.06M |
| Net Income | -33.87M | -26.31M | -55.72M | -17.62M | -24.6M | -117.09M | 47.74M | -24.06M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -32.99M | -25.08M | -18.71M | -16.57M | -23.38M | -15.65M | -15.82M | -24.34M |
| EBITDA | -32.71M | -24.8M | -18.34M | -16.23M | -23.04M | -15.3M | -15.43M | -24.01M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 2.5M | 15.45M |
| Operating Income | -1.12M | -43M | -173.27M | -126.03M | -71.37M |
| Pre Tax Income | -1.12M | -60.01M | -174.52M | -166.01M | -111.57M |
| Net Income | -1.12M | -60.01M | -174.52M | -166.01M | -111.57M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -0.102 | -1.589 | -4.536 | -2.626 | -0.597 |
| EBIT | -1.12M | -43M | -173.27M | -126.05M | -71.42M |
| EBITDA | -1.12M | -42.99M | -172.78M | -124.86M | -70M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
